Vacciguard Novel Vaccines

Vacciguard novel vaccines

 

The main challenge faced by the healthcare system is a high recurrence rate
following treatment by the existing standard therapies
Lung Cancer Vaccines - Animal Studies Print E-mail

VacciGuard's vaccine based on a 17 amino acids carrier derived from HSP-60 combined with the antigen was tested in a relevant animal model.Immunization with the antigen alone and the carrier alone served as control groups.

Mice were challenged with 10M tumor cells.

Rejection of tumors following challenge with 10M tumor cells

 

 

 

 

 

 

 

 

 

 

 

Back
 
<< Start < Prev 1 2 3 Next > End >>
Page 3 of 3